Seelos Therapeutics, Inc. Acquisition Costs, Period Cost
Seelos Therapeutics, Inc. reported Acquisition Costs, Period Cost of $585.38 thousand for the 12-month period ending 2009-12-31, per its 10-K filed 2012-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AcquisitionCosts · last filed 2012-03-13
- Seelos Therapeutics, Inc. acquisition costs, period cost for fiscal 2009 was $585.38K.
| Period end | Acquisition Costs, Period Cost 12 month |
|---|---|
| 2009-12-31 | $585.38K 10-K · filed 2012-03-13 |